A commonly held belief about cancer costs compared to other health care spending was upended by a recent COA-commissioned Milliman study. Find out how the cost to treat cancer compares with other health care spending. ...
Our European Hematology Association (EHA) meeting coverage includes an important clinical trial looking at the safety of stopping tyrosine kinase inhibitor (TKI) therapy in CML patients and an important immunotherapy study in ALL....
The next generation of immunotherapies, known as costimulators, are on the horizon, and it’s hoped that they’ll work with checkpoint inhibitors to produce a more robust immune response. But at what expense? There’s still a lot to be learned abo...